U.S. flag

An official website of the United States government

NM_000465.4(BARD1):c.568G>A (p.Asp190Asn) AND Hereditary cancer-predisposing syndrome

Germline classification:
Conflicting interpretations of pathogenicity (3 submissions)
Last evaluated:
Nov 19, 2021
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000131169.15

Allele description [Variation Report for NM_000465.4(BARD1):c.568G>A (p.Asp190Asn)]

NM_000465.4(BARD1):c.568G>A (p.Asp190Asn)

Gene:
BARD1:BRCA1 associated RING domain 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q35
Genomic location:
Preferred name:
NM_000465.4(BARD1):c.568G>A (p.Asp190Asn)
Other names:
p.D190N:GAT>AAT
HGVS:
  • NC_000002.12:g.214781306C>T
  • NG_012047.3:g.33406G>A
  • NM_000465.4:c.568G>AMANE SELECT
  • NM_001282543.2:c.511G>A
  • NM_001282545.2:c.215+15755G>A
  • NM_001282548.2:c.158+28106G>A
  • NM_001282549.2:c.364+10991G>A
  • NP_000456.2:p.Asp190Asn
  • NP_001269472.1:p.Asp171Asn
  • LRG_297t1:c.568G>A
  • LRG_297:g.33406G>A
  • LRG_297p1:p.Asp190Asn
  • NC_000002.11:g.215646030C>T
  • NG_012047.2:g.33399G>A
  • NM_000465.2:c.568G>A
  • NM_000465.3:c.568G>A
  • NR_104212.2:n.533G>A
  • NR_104215.2:n.476G>A
  • p.D190N
Protein change:
D171N
Links:
dbSNP: rs369561166
NCBI 1000 Genomes Browser:
rs369561166
Molecular consequence:
  • NM_001282545.2:c.215+15755G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001282548.2:c.158+28106G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001282549.2:c.364+10991G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000465.4:c.568G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282543.2:c.511G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NR_104212.2:n.533G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104215.2:n.476G>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000186115Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely benign
(Sep 28, 2020)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link,

SCV000910683Color Diagnostics, LLC DBA Color Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benign
(Mar 3, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV002529622Sema4, Sema4
criteria provided, single submitter

(Sema4 Curation Guidelines)
Uncertain significance
(Nov 19, 2021)
germlinecuration

PubMed (2)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

Nothing to display

See all PubMed Citations (5)

Details of each submission

From Ambry Genetics, SCV000186115.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Color Diagnostics, LLC DBA Color Health, SCV000910683.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Sema4, Sema4, SCV002529622.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 18, 2024